NEK2 and breast cancer: The oncogenic activity of NEK2 in BC has been primarily linked to regulation of centrosome splitting during mitosis [19, 20, 23], which was shown to underlie the sensitizing effect of NEK2-targeting approaches to chemotherapeutic and microtubule-poisoning agents [23, 24].